Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia
Introduction Deutetrabenazine is approved for treatment of Huntington disease (HD)-related chorea and tardive dyskinesia (TD) in adults. Factors associated with deutetrabenazine persistence and adherence are not well understood. Methods Claims data from the Symphony Health Solutions Integrated Datav...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
American Association of Psychiatric Pharmacists,
2023-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |